Entia Biosciences, Inc. (ERGO)
OTCMKTS · Delayed Price · Currency is USD
0.0003
0.00 (0.00%)
At close: Jan 27, 2026
Entia Biosciences Market Cap
Entia Biosciences has a market cap or net worth of $10.22 thousand as of February 12, 2026. Its market cap has decreased by -97.17% in one year.
Market Cap
10.22K
Enterprise Value
n/a
Revenue
265.47K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since January 18, 2008, Entia Biosciences's market cap has decreased from 3.26M to 10.22K, a decrease of -99.69%. That is a compound annual growth rate of -27.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 10.22K | - |
| Dec 31, 2025 | 10.22K | 50.00% |
| Dec 13, 2024 | 6.81K | - |
| Dec 27, 2022 | 6.81K | -86.67% |
| Dec 31, 2021 | 51.09K | -88.81% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Regenicin | 15.35K |
| Virpax Pharmaceuticals | 13.30K |
| Vaxxinity | 12.68K |
| Ampio Pharmaceuticals | 11.35K |
| Aridis Pharmaceuticals | 10.66K |
| Trevena | 10.64K |
| GeneLink | 10.60K |
| Biostax | 10.52K |